exhibit 10. 4 final final final clinical trial services agreement sponsor : advaxis, inc. sponsor : advaxis, inc. sponsor : protocol : gog - 0265 ( dtm0622 ) protocol : gog - 0265 ( dtm0622 ) protocol : protocol title : a phase ii study of lovaxin - c ( ind # 13, 712 ) in the treatment of persistent or recurrent squamous or non - squamous cell carcinoma of the cervix protocol title : a phase ii study of lovaxin - c ( ind # 13, 712 ) in the treatment of persistent or recurrent squamous or non - squamous cell carcinoma of the cervix protocol title : a phase ii study of lovaxin - c ( ind # 13, 712 ) in the treatment of persistent or recurrent squamous or non - squamous cell carcinoma of the cervix this clinical trial services agreement ( “ agreement ” ) is between advaxis, inc. ( “ sponsor ” ), a for - profit corporation organized under the laws of delaware, usa and holder of ind number 13712, and the gynecologic oncology group ( “ gog ” ), a not - for - profit corporation organized under the laws of the district of columbia, to conduct the clinical trial according to the protocol attached as exhibit a and incorporated by reference in this agreement. the principal investigator for the gog shall be philip j. disaia, m. d. the clinical trial will be directed by warner k. huh, m. d. ( “ study chair ” ), according to the protocol. 1. definitions. the following terms, when capitalized, shall have the following meanings as used in this agreement : 1. definitions. the following terms, when capitalized, shall have the following meanings as used in this agreement : 1. definitions. the following terms, when capitalized, shall have the following meanings as used in this agreement : a. “ case report form ” ( “ crf ” ) : the case history or individual research record created and maintained for each enrolled participant in the clinical trial, as required by fda regulations. a. “ case report form ” ( “ crf ” ) : the case history or individual research record created and maintained for each enrolled participant in the clinical trial, as required by